Bristol Myers climbs after forecasting upbeat 2026 profit
** Shares of drugmaker Bristol Myers Squibb BMY.N rise 3.5% to $59.56 premarket ** Co forecasts annual adj. profit between $6.05 and $6.35 per share, above analysts' estimate of $6.02 - LSEG data ** BMY reports Q4 adj. profit of $1.26/share vs analysts' estimate of $1.12/share ** Co's quarterly revenue of $12.5 billion beats analysts' expectation of $12.28 billion ** Up to last close, stock down 2.5% in the last 12 months (Reporting by Christy Santhosh) ((Christy.Santhosh@thomsonreuters.com))
Recent news on Bristol-Myers Squibb Co
See all newsFactbox: Major deals involving US drugmakers and biotechs over the past decade
Brief: Bristol Myers Squibb Announces Dividend
Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial
Factbox: Major deals involving US drugmakers and biotechs over the past decade
Izalontamab Brengitecan Shows Significant OS And PFS Improvements In TNBC And ESCC